Publicaciones en colaboración con investigadores/as de Hospital Duran i Reynals (9)

2022

  1. Activating cannabinoid receptor 2 preserves axonal health through GSK-3β/NRF2 axis in adrenoleukodystrophy

    Acta Neuropathologica, Vol. 144, Núm. 2, pp. 241-258

2019

  1. Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study

    Neurotherapeutics, Vol. 16, Núm. 4, pp. 1167-1182

2015

  1. Plerixafor in patients with lymphoma and multiple myeloma: Effectiveness in cases with very low circulating CD34+ cell levels and preemptive intervention vs remobilization

    Bone Marrow Transplantation, Vol. 50, Núm. 1, pp. 34-39

2014

  1. Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity

    Human Molecular Genetics, Vol. 23, Núm. 14, pp. 3716-3732

2009

  1. Efficacy and safety of Liposomal cytarabine in lymphoma Patients with central nervous system involvement from lymphoma

    Cancer, Vol. 115, Núm. 9, pp. 1892-1898

2008

  1. Qualitative evaluation and suggestions for improvement of the WHO Palliative Care Demonstration Programme in Catalonia at 15 years after implementation

    Medicina Paliativa, Vol. 15, Núm. 5, pp. 293-300

  2. Restricted transgene persistence after lentiviral vector-mediated fetal gene transfer in the pregnant rabbit model

    Journal of Gene Medicine, Vol. 10, Núm. 9, pp. 951-964

1993

  1. CD23 expression on B-lymphocytes and its modulation by cytokines in allergic patients

    Clinical and Experimental Allergy, Vol. 23, Núm. 7, pp. 612-617

  2. IgE antibodies against bovine serum albumin in a case of eosinophilic gastroenteritis

    Allergy, Vol. 48, Núm. 7, pp. 542-546